The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers.

Published on Jan 14, 2021in Clinical Cancer Research10.107
· DOI :10.1158/1078-0432.CCR-20-2782
Zhiyuan Hu4
Estimated H-index: 4
(University of Oxford),
Paula Cunnea7
Estimated H-index: 7
(Imperial College London)
+ 18 AuthorsAhmed Ashour Ahmed28
Estimated H-index: 28
(University of Oxford)
Sources
Abstract
Purpose: Using RNA sequencing, we recently developed the 52-gene–based Oxford classifier of carcinoma of the ovary (Oxford Classic, OxC) for molecular stratification of serous ovarian cancers (SOCs) based on the molecular profiles of their cell of origin in the fallopian tube epithelium. Here, we developed a 52-gene NanoString panel for the OxC to test the robustness of the classifier. Experimental Design: We measured the expression of the 52 genes in an independent cohort of prospectively collected SOC samples (n = 150) from a homogenous cohort who were treated with maximal debulking surgery and chemotherapy. We performed data mining of published expression profiles of SOCs and validated the classifier results on tissue arrays comprising 137 SOCs. Results: We found evidence of profound nongenetic heterogeneity in SOCs. Approximately 20% of SOCs were classified as epithelial-to-mesenchymal transition–high (EMT-high) tumors, which were associated with poor survival. This was independent of established prognostic factors, such as tumor stage, tumor grade, and residual disease after surgery (HR, 3.3; P = 0.02). Mining expression data of 593 patients revealed a significant association between the EMT scores of tumors and the estimated fraction of alternatively activated macrophages (M2; P Conclusions: The OxC-defined EMT-high SOCs carry particularly poor prognosis independent of established clinical parameters. These tumors are associated with high frequency of immunosuppressive macrophages, suggesting a potential therapeutic target to improve clinical outcome.
📖 Papers frequently viewed together
24 Citations
38 Citations
10 Authors (Luya Cai, ..., Qinqin Xiao)
3 Citations
References49
Newest
#1Christina Fotopoulou (Imperial College London)H-Index: 20
#2Nicole ConcinH-Index: 30
Last. Denis QuerleuH-Index: 49
view all 7 authors...
In 2016, the European Society of Gynaecological Oncology (ESGO) developed a list of quality indicators (QIs) for advanced ovarian cancer surgery with the aim of helping and auditing clinical practice.[1][1] The QIs were based on evidence-based research, meetings of a multidisciplinary International
6 CitationsSource
#1Li Wang (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 5
#1Li Wang (Mount Sinai Hospital)H-Index: 18
Last. Jun ZhuH-Index: 56
view all 11 authors...
BACKGROUND: Patient stratification based on molecular subtypes is an important strategy for cancer precision medicine. Deriving clinically informative cancer molecular subtypes from transcriptomic data generated on whole tumor tissue samples is a non-trivial task, especially given the various non-cancer cellular elements intertwined with cancer cells in the tumor microenvironment. METHODS: We developed a computational deconvolution method, DeClust, that stratifies patients into subtypes based on...
4 CitationsSource
#1Zhiyuan Hu (University of Oxford)H-Index: 4
#2Mara Artibani (University of Oxford)H-Index: 7
Last. Ahmed Ashour Ahmed (University of Oxford)H-Index: 28
view all 27 authors...
Summary The inter-differentiation between cell states promotes cancer cell survival under stress and fosters non-genetic heterogeneity (NGH). NGH is, therefore, a surrogate of tumor resilience but its quantification is confounded by genetic heterogeneity. Here we show that NGH in serous ovarian cancer (SOC) can be accurately measured when informed by the molecular signatures of the normal fallopian tube epithelium (FTE) cells, the cells of origin of SOC. Surveying the transcriptomes of ∼6,000 FT...
34 CitationsSource
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
#2Kimberly D. Miller (ACS: American Cancer Society)H-Index: 28
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2016) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2017) were collected by the National Center for Health Statis...
6,326 CitationsSource
#1Xianlu L. Peng (UNC: University of North Carolina at Chapel Hill)H-Index: 6
#1Xianlu Laura Peng (UNC: University of North Carolina at Chapel Hill)H-Index: 1
Last. Jen Jen Yeh (UNC: University of North Carolina at Chapel Hill)H-Index: 38
view all 5 authors...
Tumors are mixtures of different compartments. While global gene expression analysis profiles the average expression of all compartments in a sample, identifying the specific contribution of each compartment remains a challenge. With the increasing recognition of the importance of non-neoplastic components, the ability to breakdown the gene expression contribution of each is critical. Here, we develop DECODER, an integrated framework which performs de novo deconvolution and single-sample compart...
8 CitationsSource
#1Mary Goldman (UCSC: University of California, Santa Cruz)H-Index: 20
#2Brian Craft (UCSC: University of California, Santa Cruz)H-Index: 19
Last. David Haussler (UCSC: University of California, Santa Cruz)H-Index: 177
view all 12 authors...
UCSC Xena is a visual exploration resource for both public and private omics data, supported through the web-based Xena Browser and multiple turn-key Xena Hubs. This unique archecture allows researchers to view their own data securely, using private Xena Hubs, simultaneously visualizing large public cancer genomics datasets, including TCGA and the GDC. Data integration occurs only within the Xena Browser, keeping private data private. Xena supports virtually any functional genomics data, includi...
257 CitationsSource
#1Gregor Sturm (TUM: Technische Universität München)H-Index: 7
#2Francesca Finotello (Innsbruck Medical University)H-Index: 20
Last. Tatsiana AneichykH-Index: 5
view all 8 authors...
MOTIVATION: The composition and density of immune cells in the tumor microenvironment (TME) profoundly influence tumor progression and success of anti-cancer therapies. Flow cytometry, immunohistochemistry staining or single-cell sequencing are often unavailable such that we rely on computational methods to estimate the immune-cell composition from bulk RNA-sequencing (RNA-seq) data. Various methods have been proposed recently, yet their capabilities and limitations have not been evaluated syste...
145 CitationsSource
#1Philipp Harter (University of Duisburg-Essen)H-Index: 57
#2Jalid Sehouli (Charité)H-Index: 73
Last. Andreas du Bois (University of Duisburg-Essen)H-Index: 11
view all 28 authors...
Abstract Background Systematic pelvic and paraaortic lymphadenectomy has been widely used in the surgical treatment of patients with advanced ovarian cancer, although supporting evidence from rando...
156 CitationsSource
#1Haonan Lu (Imperial College London)H-Index: 7
#2Mubarik Arshad (Imperial College London)H-Index: 7
Last. Eric O. Aboagye (Imperial College London)H-Index: 50
view all 16 authors...
The five-year survival rate of epithelial ovarian cancer (EOC) is approximately 35–40% despite maximal treatment efforts, highlighting a need for stratification biomarkers for personalized treatment. Here we extract 657 quantitative mathematical descriptors from the preoperative CT images of 364 EOC patients at their initial presentation. Using machine learning, we derive a non-invasive summary-statistic of the primary ovarian tumor based on 4 descriptors, which we name “Radiomic Prognostic Vect...
49 CitationsSource
#1Gregory M Chen (Princess Margaret Cancer Centre)H-Index: 4
#1Gregory M. Chen (Princess Margaret Cancer Centre)H-Index: 10
Last. Levi Waldron (CUNY: City University of New York)H-Index: 35
view all 10 authors...
Purpose: The majority of ovarian carcinomas are of high-grade serous histology, which is associated with poor prognosis. Surgery and chemotherapy are the mainstay of treatment, and molecular characterization is necessary to lead the way to targeted therapeutic options. To this end, various computational methods for gene expression–based subtyping of high-grade serous ovarian carcinoma (HGSOC) have been proposed, but their overlap and robustness remain unknown. Experimental Design: We assess thre...
40 CitationsSource
Cited By1
Newest
#1Mara ArtibaniH-Index: 7
#2Kenta Masuda (University of Oxford)H-Index: 22
Last. Ahmed Ashour AhmedH-Index: 28
view all 31 authors...
Similar to tumor initiating cells (TICs), minimal residual disease (MRD) is capable of re-initiating tumors and causing recurrence. However, the molecular characteristics of solid tumor MRD cells and drivers of their survival have remained elusive. Here we performed dense multi-region transcriptomics analysis of paired biopsies from 17 ovarian cancer patients before and after chemotherapy. We reveal that while MRD cells share important molecular signatures with TICs, they are also characterized ...
Source